Free Trial

Solventum (SOLV) Competitors

Solventum logo
$73.08 -1.42 (-1.90%)
Closing price 03:59 PM Eastern
Extended Trading
$72.50 -0.58 (-0.80%)
As of 07:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SOLV vs. GEHC, PHG, ZBH, SNN, PEN, GKOS, STVN, BLCO, INSP, and NARI

Should you be buying Solventum stock or one of its competitors? The main competitors of Solventum include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Stevanato Group (STVN), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), and Inari Medical (NARI). These companies are all part of the "medical equipment" industry.

Solventum vs.

GE HealthCare Technologies (NASDAQ:GEHC) and Solventum (NYSE:SOLV) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment, community ranking and analyst recommendations.

In the previous week, GE HealthCare Technologies had 9 more articles in the media than Solventum. MarketBeat recorded 20 mentions for GE HealthCare Technologies and 11 mentions for Solventum. GE HealthCare Technologies' average media sentiment score of 0.98 beat Solventum's score of 0.95 indicating that GE HealthCare Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GE HealthCare Technologies
13 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Solventum
6 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.3% of GE HealthCare Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

GE HealthCare Technologies currently has a consensus price target of $97.67, indicating a potential upside of 7.67%. Solventum has a consensus price target of $68.29, indicating a potential downside of 6.03%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, equities research analysts clearly believe GE HealthCare Technologies is more favorable than Solventum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GE HealthCare Technologies
1 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.69
Solventum
1 Sell rating(s)
9 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

GE HealthCare Technologies received 23 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 60.00% of users gave GE HealthCare Technologies an outperform vote while only 5.56% of users gave Solventum an outperform vote.

CompanyUnderperformOutperform
GE HealthCare TechnologiesOutperform Votes
24
60.00%
Underperform Votes
16
40.00%
SolventumOutperform Votes
1
5.56%
Underperform Votes
17
94.44%

GE HealthCare Technologies has a net margin of 10.13% compared to Solventum's net margin of 0.00%. GE HealthCare Technologies' return on equity of 25.74% beat Solventum's return on equity.

Company Net Margins Return on Equity Return on Assets
GE HealthCare Technologies10.13% 25.74% 6.29%
Solventum N/A N/A N/A

GE HealthCare Technologies has higher revenue and earnings than Solventum.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GE HealthCare Technologies$19.67B2.11$1.99B$4.3320.95
SolventumN/AN/AN/AN/AN/A

Summary

GE HealthCare Technologies beats Solventum on 14 of the 14 factors compared between the two stocks.

Get Solventum News Delivered to You Automatically

Sign up to receive the latest news and ratings for SOLV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SOLV vs. The Competition

MetricSolventumSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$12.52B$4.58B$5.80B$20.06B
Dividend YieldN/A39.91%4.78%3.65%
P/E RatioN/A30.4926.3234.91
Price / SalesN/A49.75452.0815.74
Price / CashN/A51.2344.0420.85
Price / BookN/A6.567.644.93
Net IncomeN/A$90.13M$3.18B$1.02B
7 Day Performance-1.85%-2.14%-1.66%-0.92%
1 Month Performance-1.72%-2.13%0.41%-1.26%
1 Year PerformanceN/A15.32%17.47%14.15%

Solventum Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SOLV
Solventum
0.399 of 5 stars
$73.08
-1.9%
$68.29
-6.6%
N/A$12.62BN/A0.0022,000Upcoming Earnings
GEHC
GE HealthCare Technologies
3.2537 of 5 stars
$92.21
-1.4%
$97.67
+5.9%
+6.6%$42.13B$19.55B25.3351,000Positive News
PHG
Koninklijke Philips
3.0759 of 5 stars
$28.16
-1.6%
N/A+24.2%$26.47B$19.66B-67.0469,656Earnings Report
Analyst Upgrade
News Coverage
Positive News
ZBH
Zimmer Biomet
4.7576 of 5 stars
$100.52
+0.6%
$124.15
+23.5%
-17.1%$20.01B$7.68B22.5918,000Positive News
SNN
Smith & Nephew
2.4815 of 5 stars
$25.72
+0.0%
N/A-9.8%$11.24B$5.55B0.0018,452Upcoming Earnings
PEN
Penumbra
4.4579 of 5 stars
$267.83
-1.9%
$261.36
-2.4%
+12.7%$10.28B$1.06B311.434,200Earnings Report
Analyst Forecast
Analyst Revision
News Coverage
GKOS
Glaukos
4.3976 of 5 stars
$153.06
+4.6%
$151.08
-1.3%
+71.4%$8.44B$314.71M-50.68780Earnings Report
Analyst Upgrade
Insider Trade
News Coverage
Gap Down
STVN
Stevanato Group
1.236 of 5 stars
€19.49
+2.2%
N/A-32.5%$5.90B$1.17B41.475,635Positive News
BLCO
Bausch + Lomb
3.7366 of 5 stars
$16.44
-1.2%
$20.25
+23.2%
+9.1%$5.79B$4.15B-15.6513,300Earnings Report
Analyst Forecast
Analyst Revision
News Coverage
INSP
Inspire Medical Systems
4.8316 of 5 stars
$184.73
-1.3%
$228.82
+23.9%
-7.0%$5.54B$624.80M172.651,011Insider Trade
NARI
Inari Medical
1.6759 of 5 stars
$79.93
flat
$68.00
-14.9%
+37.6%$4.68B$493.63M-59.211,300

Related Companies and Tools


This page (NYSE:SOLV) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners